EU approves smallpox vaccine for use against monkeypox
Approval of Imvanex comes after the World Health Organization declared monkeypox a global health emergency.
The European Union’s executive arm has approved a smallpox vaccine for use against monkeypox after the World Health Organization (WHO) declared its spread a global health emergency, the Danish drugmaker that developed the jab said.
“The European Commission has extended the marketing authorisation for the company’s smallpox vaccine, Imvanex, to include protection from monkeypox” in line with a recommendation by the EU’s medicines watchdog, Bavarian Nordic said in a statement on Monday.
“The approval … is valid in all European Union Member States as well as in Iceland, Liechtenstein, and Norway.”
The European Medicines Agency (EMA) carries out a scientific assessme...